Respiratory Infections News

An analysis of online conversations among health care professionals on social media during September revealed mixed reactions toward newly updated messenger RNA COVID-19 vaccines.

BOSTON — White and Black patients in rural areas face an increased risk for hospital-associated infections, and Black rural patients experience the highest risks for ICU admission an in-hospital death, researchers reported at IDWeek.

BOSTON — Sub-Saharan African countries supported by the U.S. President’s Emergency Plan for AIDS Relief, or PEPFAR, tested for COVID-19 at three times the rate of non-PEPFAR nations, according to data presented at IDWeek.

A new study links some neurocognitive symptoms of long COVID to persistent SARS-CoV-2 infection in the gut, which triggers a series of reactions that lowers serotonin levels.

Nirsevimab, a monoclonal antibody recently approved to prevent respiratory syncytial virus-associated lower respiratory disease in newborns and infants, may protect longer than an RSV season, researchers reported at IDWeek.

People infected with COVID-19 have a higher risk of cardiovascular/cerebrovascular complications. However, researchers found that these risks can be reduced with vaccination and boosting.

BOSTON — The Infectious Diseases Society of America is focused on growing the ID workforce and increasing opportunities for its members, its new president told Healio at IDWeek.

Vaccine mandates played a significant role in boosting influenza vaccination rates during the 2020-2021 influenza season, researchers reported in Pediatrics.

BOSTON — GSK’s respiratory syncytial virus vaccine had a sustained effectiveness of around 67% among adults aged 60 years or older across two full RSV seasons, researchers reported at IDWeek.

COVID-19 vaccination was associated with a reduced likelihood of long COVID among children infected with SARS-CoV-2 during the omicron wave, according to study findings presented at IDWeek.